Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Greve

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Archives of Medical Research|July 23, 2023
Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast CancerTiffany S Haiduk, Mark Sicking, Kathrin A Brücksken, et al.
Frontiers in Cell and Developmental Biology|August 22, 2025
Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphomaTimo Habig, Lasse Reichstein, Kathrin A Brücksken, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 12, 2025
Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasionArgyris Spyrou, Ananya Roy, Anqi Xiong, et al.
International Journal of Molecular Sciences|June 2, 2021
Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer CellsSofía Valla, Nourhan Hassan, Daiana Luján Vitale, et al.
Plos One|February 22, 2020
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcomaCaroline Brand, Burkhard Greve, Tobias Bölling, et al.
Frontiers in Cell and Developmental Biology|October 26, 2020
The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell PropertiesFelipe C O B Teixeira, Archana Vijaya Kumar, Sampath Kumar Katakam, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 9, 2025
Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working groupKhaled Elsayad, Dora Correia, Ulrike Theiß, et al.
Plos One|January 7, 2014
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signalingSherif A Ibrahim, Hebatallah Hassan, Laura Vilardo, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 15, 2009
Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivityBurkhard Greve, Kristin Dreffke, Astrid Rickinger, et al.
International Journal of Molecular Sciences|April 5, 2020
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast CancerFabian M Troschel, Annemarie Minte, Yahia Mahmoud Ismail, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Archives of Medical Research|July 23, 2023
Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast CancerTiffany S Haiduk, Mark Sicking, Kathrin A Brücksken, et al.
Frontiers in Cell and Developmental Biology|August 22, 2025
Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphomaTimo Habig, Lasse Reichstein, Kathrin A Brücksken, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 12, 2025
Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasionArgyris Spyrou, Ananya Roy, Anqi Xiong, et al.
International Journal of Molecular Sciences|June 2, 2021
Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer CellsSofía Valla, Nourhan Hassan, Daiana Luján Vitale, et al.
Plos One|February 22, 2020
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcomaCaroline Brand, Burkhard Greve, Tobias Bölling, et al.
Frontiers in Cell and Developmental Biology|October 26, 2020
The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell PropertiesFelipe C O B Teixeira, Archana Vijaya Kumar, Sampath Kumar Katakam, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 9, 2025
Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working groupKhaled Elsayad, Dora Correia, Ulrike Theiß, et al.
Plos One|January 7, 2014
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signalingSherif A Ibrahim, Hebatallah Hassan, Laura Vilardo, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 15, 2009
Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivityBurkhard Greve, Kristin Dreffke, Astrid Rickinger, et al.
International Journal of Molecular Sciences|April 5, 2020
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast CancerFabian M Troschel, Annemarie Minte, Yahia Mahmoud Ismail, et al.
Pageof 9